Korean Pharmas To Highlight Lung Cancer Pipeline Progress At AACR

Several South Korean companies are set to present updates on their growing lung cancer pipelines at a major meeting in...

      

Related Stories

• Alexion's Pipeline Rebuild Plan Targets Wilson's Liver Drug, More M&A Likely
• Executive Interview: Vectura's Ward-Lilley On Re-Focusing On The Respiratory Sector
• How Is Pharma Spending Tax Savings? Not On Drug Pricing, Sen. Booker Says

 

Original Article: Korean Pharmas To Highlight Lung Cancer Pipeline Progress At AACR

More From BioPortfolio on "Korean Pharmas To Highlight Lung Cancer Pipeline Progress At AACR"